Average Co-Inventor Count = 4.10
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pfizer Corporation (15 from 4,455 patents)
2. Sloan-kettering Institute for Cancer Research (3 from 512 patents)
3. Pfizer Products Inc. (1 from 47 patents)
18 patents:
1. 11634410 - Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
2. 10988463 - Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
3. 10787438 - Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
4. 10174007 - Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
5. 9809579 - Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
6. 7462600 - Macrolides
7. 7250518 - Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
8. 7183293 - Ether derivatives useful as inhibitors of PDE4 isozymes
9. 7060717 - Nicotinamide derivatives useful as PDE4 inhibitors
10. 6953810 - Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11. 6949573 - Nicotinamide derivatives useful as PDE4 inhibitors
12. 6828333 - Ether derivatives useful as inhibitors of PDE4 isozymes
13. 6756392 - Nicotinamide derivatives useful as PDE4 inhibitors
14. 6740655 - Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
15. 6649633 - Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes